Neurosteroids, brain damage, and mental illness

Experimental Gerontology

Volumn 33, Issue 7-8, 1998, Pages 713-727

  Herbert, J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Aging; Brain damage; Cortcoids; CSF; Depression; DHEA; Hippocampus; Life events; Neurotoxins; Saliva; Stress

Indexed keywords

CORTICOSTEROID; NEUROSTEROID; PRASTERONE;

AGING; BRAIN FUNCTION; BRAIN INJURY; CEREBROSPINAL FLUID; CONFERENCE PAPER; DEPRESSION; HIPPOCAMPUS; HUMAN; LIFE EVENT; LIFE EXPECTANCY; MALADJUSTMENT; MENTAL DISEASE; NEUROPROTECTION; PRIORITY JOURNAL; QUALITY OF LIFE; SALIVA; WELLBEING;

ADRENAL CORTEX HORMONES; ANIMALS; BRAIN DAMAGE, CHRONIC; DEHYDROEPIANDROSTERONE; HUMANS; HYDROCORTISONE; MENTAL DISORDERS;

EID: 0032442415     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(98)00039-4     Document Type: Conference Paper

References (62)

1. Barrett-Connor, E. and Khaw, K.-, T. The epidemiology of DHEAS with particular reference to cardiovascular disease: The Rancho Bernardo Study. In: The Biologic Role of Dehydroepiandrosterone (DHEA), Kalimi, M. and Regelson, W. (Editors), pp. 281-298, de Gruyter, Berlin, 1990.
2. Blauer K.L., Poth M., Rogers W.M., Bernton E.W. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology. 129:1991;3174-3179.
3. Brown, G.W. and Harris, T.O. , (Editors). Life Events and Illness. Unwin Hyman, London, 1989.
4. Carette B., Poulain P. Excitatory effect of dehydroepiandrosterone, its sulphate ester and pregnenolone sulphate, applied by ionophoresis and pressure, on single neurons in the septo-preoptic area of the guinea pig. Neurosci. Lett. 45:1984;205-210.
5. Carroll B.J., Curtis G.C., Mendels J. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol. Med. 6:1976;235-247.
6. Cawood E.H.H., Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psychol. Med. 26:1996;925-936.
7. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
8. 3H]D-aspartate overflow in hippocampal cultures during cyanide-induced ishemia. Brain Res. 654:1994;8-14.
9. Clark D.A., Beck A.T., Beck J.S. Symptom differences in major depression, dysthymia, panic disorder and generalised anxiety disorder. Am. J. Psychiatry. 151:1994;205-209.
10. Corpechot C., Robel P., Axelson M., Sjovall J., Baulieu E.-. E. Characterisation and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. 78:1981;4704-4707.
11. De Kloet E.R. Brain corticosteroid receptor balance and homeostatic control. Front. Neuroendocrinol. 12:1991;95-164.
12. A receptor. Neuroscience. 45:1991;127-135.
13. Devesa J., Perez-Fernandez R., Bokser L., Casanueva F.F. Adrenal androgen secretion and dopaminergic activity in anorexia nervosa. Horm. Metab. Res. 20:1988;57-60.
14. 2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J. Biol. Chem. 271:1996;2024-2028.
15. Goodyer, I.M., Herbert, J., Altham, P.M.E., Pearson, J., Secher, S.M., and Shiers, H.M. , Adrenal secretion during major depression in 8 to 16 year olds I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation Psychol. Med. 26, 245-256, 1996.
16. Goodyer I.M., Herbert J., Altham P.M.E. Adrenal secretion during major depression in 8 to 16 year olds III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol. Med. 28:1998;265-273.
17. Guazzo E.P., Kirkpatrick P.J., Goodyer I.M., Shiers H.M., Herbert J. Cortisol, dehydroepiandrosterone (DHEA) and its sulphate (DHEAS) in the cerebrospinal fluid of man Relation to blood levels and the effects of age . J. Clin. Endocrinol. Metab. 81:1996;3951-3960.
18. Herbert J. Peptides in the limbic system Neurochemical codes for co-ordinated adaptive responses to behavioral and physiological demand . Prog. Neurobiol. 41:1993;723-791.
19. Herbert J. Stress, the brain and mental illness. Br. Med. J. 315:1997;530-535.
20. Herbert J., Goodyer I.M., Altham P.M.E., Pearson J., Secher S.M., Shiers H.M. Adrenal secretion during major depression in 8 to 16 year olds II. Influence of comorbidity at presentation. Psychol. Med. 26:1996;257-263.
21. Herbert J. The age of dehydroepiandrosterone. Lancet. 345:1995;1193-1194.
22. Holmes T.H., Rahe R.H. The social readjustment scale. J. Psychosom. Res. 11:1967;213-218.
23. Hortnagl H., Berger M.L., Havelec L., Hornykiewicz O. Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethlcholine aziridinium (AF64A). J. Neurosci. 13:1993;2939-2945.
24. Kelly W.F., Checkley S.A., Bender D.A., Mashiter K. Cushing's syndrome and depression - A prospective study of 26 patients. Br. J. Psychiatry. 142:1983;16-19.
25. Khaw K-T, Tazuke S., Barret-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N. Engl. J. Med. 318:1988;1705-1709.
26. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad Sci. USA. 95:1998;1852-1857.
27. Kimonides, V.G., Spillantini, M.G., Sofroniew, M.V., Fawcett, J.W., and Herbert, J., Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in primary hippocampal cultures. Neuroscience (in press).
28. Lewis D.A., Smith R.E. Steroid-induced psychiatric syndromes. J. Affect. Disorders. 5:1983;319-332.
29. Loosen P.T. Cushings syndrome and depression. Endocrinologist. 4:1994;373-382.
30. Lupien S.J., De Leon M., De Santi S., Convit A., Tarshish C., Nair N.P.V., Thakur M., McEwen B.S., Hauger R.L., Meaney M.J. Cortisol levels duroing human aging predict hippocampal atrophy and memory deficits. Nat. Neurosi. 1:1998;69-73.
31. Magarinos A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons Comparison of stressors . Neuroscience. 69:1995;83-88.
32. A receptor. Mechanisms of action and physiological significance . Prog. Neurobiol. 38:1992;379-395.
33. Martensz N.D., Herbert J., Stacey P.M. Factors regulating levels of cortisol in cerebrospinal fluid of monkeys during acute or chronic hypercortisolaemia. Neuroendocrinology. 36:1983;39-48.
34. May M., Holmes E., Rogers W., Poth M. Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. Life Sci. 46:1991;1627-1631.
35. McIntosh, M.K., Pan, J-S., and Berdanier, C.D. , In vitro studies on the effects of dehydroepiandrosterone and corticosterone on hepatic steroid receptor binding and mitochondrial respiration. Comp. Biochem. Physiol.104A, 147-153, 1993.
36. Meaney M.J., Aitken D.H., Vanberkel C., Bhatnagar S., Sapolsky R.M. Effect of neonatal handling on age-related impairments associate with the hippocampus. Science. 239:1988;766-768.
37. Mohan P.F., Cleary M.P. Studies on nuclear binding of dehydroepiandrosterone in hepatocytes. Steroids. 57:1992;244-247.
38. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78:1994;1360-1367.
39. Murros K., Fogelholm R., Kettunen S., Vuorela A.-L. Serum cortisol and outcome of ischemic brain infarction. J. Neurol. Sci. 116:1993;12-17.
40. O'Dwyer A.-M., Lightman S.L., Marks M.N., Checkley S.A. Treatment of major depression with metyrapone and hydrocortisone. J. Affect. Disorders. 33:1995;123-128.
41. Olsson T., Marklund N., Gustafson Y., Nasman B. Abnormalities at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke. Stroke. 23:1992;1573-1576.
42. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum ehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59:1984;551-555.
43. Orentreich N., Brind J.L., Vogelman J.H., Andres R., Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J. Clin. Endocrinol. Metab. 75:1992;1002-1004.
44. Osran H., Reist C., Chen C.C., Lifrak E.T., Chicz-Demet A., Parker L.N. Adrenal androgens and cortisol in major depression. Am. J. Psychiatry. 150:1993;806-809.
45. Pardridge W.M., Mietus L.J. Transport of steroid hormones through the blood-brain barrier. Primary role of albumin-bound hormone. J. Clin. Invest. 64:1979;145-154.
46. Parker L.N., Sack J., Fisher D.A., Odell W.D. The adrenarche Prolactin, gonadotropins, adrenal androgens and cortisol . J. Clin. Endocrinol. Metab. 46:1978;396-401.
47. Paykel, E.S. and Cooper, Z. , Life events and social stress. In: Handbook of Affective Disorders, (Paykel, E.S., (Editor)) 2nd ed., pp. 149-170 Churchill, Livingstone, 1992.
48. Sapolsky R.M. Why stress is bad for your brain. Science. 273:1996;749-750.
49. Sapolsky R.M. , Stress, glucocorticoids, and damage to the nervous system: The current state of confusion. Stress 1, 1-19, 1996b.
50. Schneider L.S., Hinsey M., Lyness S. Plasma dehydroepiandrosterone sulfate in Alzheimer's disease. Biol. Psychiatry. 31:1992;205-208.
51. Schwarzschild M.A., Cole R.L., Hyman S.E. Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons. J. Neurosci. 17:1997;3455-3466.
52. Selye, H. , The Stress of Life. McGraw-Hill, New York, 1978.
53. Shafagoj Y., Opuku J., Quereshi D., Regelson W., Kalimi M. Dehydroepiandrosterone prevents dexamethasone-induced hypertension in rats. Am. J. Physiol. 263:1992;E210-E213.
54. Siiteri P.K., Murai J.T., Hammond G.L., Nisker H.A., Raymoure W.J., Kuhn R.W. The serum transport of steroid hormones. Rec. Prog. Horm. Res. 32:1982;457-504.
55. Tarbuck A.F., Paykel E.S. Effects of age on cognitive function of younger and older subjects. Psychol. Med. 25:1995;285-295.
56. Tombaugh G.C., Yang S.H., Swanson R.A., Sapolsky R.M. Glucocorticoids exacerbate hypoxic and hypoglycemic hippocampal injury in vitro Biochemical correlates and a role for astrocytes . J. Neurochem. 59:1992;137-146.
57. Van Londen L., Goekoop J.G., Zwinderman A.H., Lanser J.B.K., Wiegant V.M., De Wied D. Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression. Psychol. Med. 28:1998;275-284.
58. Virgin C.E., Ha T.P.T., Packan D.R., Tombaugh G.C., Yang S.H., Horner H.C., Sapolsky R.M. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes - Implications for glucocorticoid neurotoxicity. J. Neurochem. 57:1991;1422-1428.
59. Winterer J., Gwirtsman D.R., George D.T., Cutler B. Adrenocorticotropin-stimulated adrenal secretion in anorexia nervosa Impaired secretion at low weight with normalization after recovery . J. Clin. Endocrinol. Metab. 61:1985;693-697.
60. Wolkowitz O.M. Prospective controlled-studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology. 19:1994;233-255.
61. Wolkowitz O.M., Reus V.I., Roberts E. Antidepressant and cognition enhancing effects of DHEA in major depression. Ann. NY Acad. Sci. 774:1995;337-339.
62. Zumoff B., Walsh B.T., Katz J.L., Levin J., Rosenfeld R.S., Kream J., Weiner H. Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa A second hormonal parameter of ontogenetic regression . J. Clin. Endocrinol. Metab. 56:1983;668-672.